A meta-analysis and systematic review of randomized controlled trials with degarelix versus gonadotropin-releasing hormone agonists for advanced prostate cancer: Erratum

In the article “A meta-analysis and systematic review of randomized controlled trials with degarelix versus gonadotropin-releasing hormone agonists for advanced prostate cancer”,^[1] which appeared in Volume 95, Issue 27 of Medicine, the fourth line of Table 2, “PSA progression-free survival in metastatic cases” was given incorrectly. The entry should have read “PSA progression rates in metastatic cases”.